Dear Shareholder,
With a series of vital research, partnerships and product catalysts to come, we are about to learn about the immense promise we have cultivated in recent years, and we must begin today by expressing our deep gratitude for their commitment and patience as we paint to build anything that has revolutionary potential.
Bioelectronic medicine is a continuous advance, with a forged basis and in the development of valid peer-reviewed studies in the status quo of the medical sciences that now confirms what we have known for years: it works.
More than 100 million Americans suffer from some form of chronic pain. Globally, experts estimate that the chronic pain market is an opportunity that is expected to be successful at $ 69 billion to $ 105 billion in the next few years. But the existing responses to this epidemic are woefully inadequate. According to data from the National Institutes of Health (NIH), in 2018, more than 128 people died every day from opioid-related drug overdoses.
Social estating measures and orders to stay home across the country have been implemented to involve the unpredictable and worsened spread of the COVID-19 virus, which will have adverse effects on people with chronic pain and in Americans with opioids.Consumption disorders, which are already vulnerable and rely heavily on the provision of in-person fitness care.CNN recently reported that the opioid crisis in the United States would worsen after the COVID-19 pandemic.Our device can be used as an option for face-to-face remedies for home use and monitored remotely through fitness professionals.
At Electromedical Technologies, our generation has been shown to be very effective for over 10 years with the right results for the patient and no dangers related to pills or side effects.Other corporations are also starting to invest in this space, as recently reported on the cover.of Time mag ‘Electrifying Medicine’.
We’ve already made wonderful progress. Our contract with the FSS va government (number V797D-40250) sells us to any VA, DAPA or government facility.We have already sold 8,000 games of our WellnessPRO®, with customers, adding more than 250 schools and universities, which use our devices in their sports departments and curriculum, and a number of professional athletes and sports groups in the NBA, NHL and NFL.
We have signed a collaboration agreement with Nazarbayev University, Nur-Sultan, Kazakhstan, to expand a comprehensive curriculum on defining the effects of electromodulation on a physiological state of the human body through the effects of the electrical fields chosen in cell signaling.It is also interesting to expand electromodulation studies to identify the maximum effective frequencies that interfere with replication and the encounter of giant single-category RNA viruses.
In addition, we have implemented a program for physicians in bioelectronics with the California College of Natural Medicine (CCNM) in partnership with Electromedical Technologies, which is awaiting state approval, creating a professional program that will provide school credits to physicians and increase awareness of bioelectronics.technologies, as well as our WellnessPro product line®.
We are also able to expand with our new device, WellnessPro® POD, which is expected to launch soon, and we hope it will treat not only chronic pain, but also new frequency modalities that naturally exploit the body’s electrochemistry.without the use of potentially destructive drugs.
We have many new updates very close or long term, as well as news about partnerships, study results, approvals and long-term progress on the R side
Kind regards
Matthew Wolfson, CEO
Electromedical Technologies, Inc.
About electromedical technologies
For more information, https://electromedtech.com
Safe Harbor Statement
This press release comprises forward-looking statements based on existing expectations or beliefs, as well as a number of assumptions about long-term occasions. While we believe that the expectations reflected in the forward-looking statements and the assumptions on which they are based are reasonable, we cannot guarantee or warrant that such expectations and assumptions will be correct. Forward-looking statements can sometimes be identified by the use of words such as “may”, “will”, “should”, “may simply”, “expect”, “anticipate”, “estimate”, “”, “have”. objective ”or“ assignment ”or the negative of those words or other diversifications of those words or comparable terminology. The reader is cautioned not to improperly rely on such forward-looking statements, as such statements are subject to many points and uncertainties, adding, but not limited to: adverse economic conditions, competition, adverse government regulation, federal, state and local regulation, inadequate capital , inability to carry out research, progression and commercialization plans, loss or retirement of key executives and other express dangers. To the extent that the statements contained in this press release are not strictly historical, adding statements regarding profit allocations, business strategy, prospects, objectives, long-term milestones, plans, goals, objectives, long-term monetary conditions , occasions conditioned through shareholders or any other approval, or otherwise, with respect to long-term occasions, such statements are forward-looking and are made in accordance with the safe harbor provisions of the Private Securities Litigation Reform Act 1995. The forward-looking statements contained in this press release are subject to certain dangers and uncertainties that may cause actual effects that differ materially from the statements made.
Company Contact:
Public Relations:
See our spouse here